Michael Pogorzelski

Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy

Michael Pogorzelski, Saskia Ting, Thomas Gauler et al. · Cell Death and Disease · 2014 · 27 citations · Full text

Medicine, Immunology, Oncology +17

Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study

Kelly G. Paulson, Sally C. M. Lau, Myung‐Ju Ahn et al. · The Lancet Oncology · 2025 · 25 citations

Medicine, Oncology, Pharmacology +16

PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study

Caner Civan, Stefan Kasper, Christoph Berliner et al. · Journal of Nuclear Medicine · 2022 · 17 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Molecular dissection of effector mechanisms of <i>RAS</i>-mediated resistance to anti-EGFR antibody therapy

Stefan Kasper, Henning Reis, Sophie Ziegler et al. · Oncotarget · 2017 · 15 citations · Full text

Medicine, Cancer Biology, Oncology +15

OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study

Shu Ping Lau, M-J. Ahn, Mor Moskovitz et al. · Journal of Thoracic Oncology · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17